Out of the many new drugs in development, Igor Puzanov, MD, MSCI, FACP, selected those that seem the most promising. In this lecture he will discuss the novel classes of promising agents in development, how to enhance immune response in patients, and describe the promise of precision therapy.
Senior Vice President, Clinical Investigation
Professor of Oncology, Department of Medicine
Director, Center for Early Phase Clinical Trials
Chief, Early Phase Clinical Trials Division
Chief, Melanoma Section
In my role as a Clinical Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, I am developing novel therapies for patients with cancer...